Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
About This Series
Functional gastrointestinal disorders affect approximately 40 million people in the United States, and the toll in terms of burden of disease on individuals and the healthcare system is significant. Patients and clinicians alike are not satisfied with traditional treatment options, and it is hoped that recent and emerging additions to the therapeutic armamentarium will improve outcomes. Taryn Brill hosts this series of expert perspectives by a leader in the field of irritable bowel syndrome, who will explore treatment options for patients with functional disorders of constipation and diarrhea.
Functional gastrointestinal disorders affect approximately 40 million people in the United States, and the toll in terms of burden of disease on individuals and the healthcare system is significant. Patients and clinicians alike are not satisfied with traditional treatment options, and it is hoped that recent and emerging additions to the therapeutic armamentarium will improve outcomes. Taryn Brill hosts this series of expert perspectives by a leader in the field of irritable bowel syndrome, who will explore treatment options for patients with functional disorders of constipation and diarrhea.
Host
Taryn Brill
Medical Journalist,
New York, New York
Faculty
Darren M. Brenner, MD
Associate Professor of Medicine and Surgery
Northwestern University Feinberg School of Medicine
Chicago, Illinois
Supported by an independent educational grant from